---
title: "Kiniksa Pharmaceuticals (KNSA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KNSA.US/norm.md"
symbol: "KNSA.US"
name: "Kiniksa Pharmaceuticals"
parent: "https://longbridge.com/en/quote/KNSA.US.md"
datetime: "2026-05-20T12:31:27.707Z"
locales:
  - [en](https://longbridge.com/en/quote/KNSA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KNSA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KNSA.US/norm.md)
---

# Kiniksa Pharmaceuticals (KNSA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.2700 | 0.1809 | 0.2300 | 0.2300 | 0.1100 |
| ROE | 15.40% | 10.30% | 14.31% | 14.98% | 7.62% |
| Revenue | 214.27M | 202.13M | 180.85M | 156.80M | 137.78M |
| Net income | 22.59M | 14.20M | 18.43M | 17.83M | 8.54M |
| Operating income | 29.27M | 19.77M | 24.02M | 20.16M | 13.27M |
| Gross margin | 55.02% | 54.99% | 53.80% | 54.71% | 55.25% |
| Net margin | 10.54% | 7.02% | 10.19% | 11.37% | 6.20% |
| Profit quality | 58.30% | 36.68% | 71.33% | 71.77% | 59.45% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 825.28M | 763.63M | 712.33M | 661.15M | 599.33M |
| Leverage | 1.36 | 1.35 | 1.33 | 1.34 | 1.31 |
| BVPS | 8.22 | 7.44 | 7.10 | 6.69 | 6.28 |
| Turnover | 1.06 | 1.01 | 0.9434 | 0.8796 | 0.8600 |
| Cash & STI | 468.09M | 414.07M | 352.10M | 307.78M | 268.34M |
| Inv & Rec | 73.14M | 54.90M | 41.40M | 48.18M | 22.07M |
| LT assets | 11.32M | 11.75M | 11.73M | 11.38M | 11.06M |
| Net debt | -459.07M | -404.58M | -342.38M | -298.02M | -258.43M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 50.20M | 53.89M | 33.68M | 28.09M | 22.32M |
| Investing CF | -31.92M | -70.81M | -62.76M | -3.88M | -51.54M |
| Financing CF | 6.07M | 7.66M | 11.90M | 10.70M | 2.77M |
| Free CF | 32.92M | 48.05M | 19.56M | 17.04M | 13.24M |
| OCF coverage | 31179.50% | 8514.06% | 5018.93% | 17024.24% | 22549.49% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -161000.00 | -633000.00 | -671000.00 | -165000.00 | -99000.00 |